Antimicrobial Resistance (AMR)

Antimicrobial Resistance (AMR) poses a severe global and national health threat, with Kenya experiencing significant mortality rates attributable to drug-resistant infections. The National Environment Management Authority (NEMA) plays a critical, albeit often understated, role in Kenya's multi-sectoral "One Health" approach to combating AMR. This article examines NEMA's legal and regulatory mandate under the Environmental Management and Co-ordination Act (EMCA), 1999, focusing on its responsibilities in waste management, pollution control, and environmental impact assessments. It highlights how NEMA's functions are crucial in mitigating the environmental spread of antimicrobials and resistant microorganisms, while also addressing the challenges of inter-agency coordination and the need for strengthened enforcement and dedicated resources within the broader national AMR strategy.

Antimicrobial Resistance (AMR) has emerged as one of the most pressing global health challenges of our time, threatening the efficacy of modern medicine and posing significant risks to human, animal, and environmental health. In Kenya, the burden of AMR is substantial, with thousands of deaths annually attributed to drug-resistant infections. The World Health Organization (WHO) and other international bodies advocate for a "One Health" approach to combat AMR, recognizing the interconnectedness of human, animal, and environmental health.

While much attention is often directed towards the human and animal health sectors, the environmental dimension of AMR, particularly the role of environmental regulators, is equally critical. The National Environment Management Authority (NEMA) in Kenya is mandated to oversee environmental management and coordination, placing it at the forefront of efforts to prevent the environmental dissemination of antimicrobial residues and resistant microorganisms. This article delves into NEMA's legal and regulatory framework in the context of AMR, exploring its specific responsibilities and the challenges it faces in contributing effectively to Kenya's national AMR strategy.

This analysis will demonstrate that NEMA's robust mandate under the Environmental Management and Co-ordination Act (EMCA) provides a strong foundation for its engagement with AMR. However, effective implementation requires enhanced inter-sectoral collaboration, clearer delineation of roles, and adequate resourcing to fully operationalize the "One Health" principle, particularly in addressing critical environmental pathways such as pharmaceutical waste disposal and effluent management.

The "One Health" concept, which underpins Kenya's strategy to combat AMR, emphasizes that the health of humans, animals, and the environment are inextricably linked. This holistic approach necessitates coordinated efforts across various sectors, including health, agriculture, and environment, to effectively prevent and contain AMR. Globally, the Quadripartite alliance, comprising the WHO, Food and Agriculture Organization (FAO), World Organisation for Animal Health (WOAH, formerly OIE), and the United Nations Environment Programme (UNEP), champions this integrated strategy.

In Kenya, the primary legal framework for environmental governance is the Environmental Management and Co-ordination Act, 1999 (Cap 387) (EMCA). EMCA established NEMA as the principal instrument of government responsible for the implementation of all policies relating to the environment, and for exercising general supervision and coordination over all environmental matters. NEMA is empowered to develop regulations, prescribe measures and standards, and issue guidelines for the management and conservation of natural resources and the environment. This broad mandate positions NEMA as a key player in addressing the environmental aspects of AMR.

Complementing EMCA, other sectoral laws indirectly contribute to AMR control by regulating related activities. These include the Public Health Act (Cap 242), which governs public health standards; the Pharmacy and Poisons Act (Cap 244), which regulates the practice of pharmacy and control of medicines; and the Food, Drugs and Chemical Substances Act (Cap 254), which controls the quality and safety of food, drugs, and chemical substances. While these acts primarily focus on human and animal health, their provisions on drug quality, use, and disposal intersect significantly with NEMA's environmental protection mandate, particularly regarding the prevention of antimicrobial contamination in the environment. Kenya has also developed a National Policy for the Prevention and Containment of Antimicrobial Resistance and a National Action Plan on Prevention and Containment of Antimicrobial Resistance (NAP-AMR 2023-2027), which explicitly include NEMA as an implementing institution.

NEMA's mandate under EMCA provides several avenues through which it can, and should, actively combat AMR. Firstly, its role in **waste management** is paramount. EMCA and its subsidiary regulations, such as the Environmental Management and Co-ordination (Waste Management) Regulations, impose obligations for the proper collection, segregation, storage, transportation, and disposal of all waste, including pharmaceutical waste. Improper disposal of medicines, untreated or poorly treated waste from hospitals and industries, and animal waste from farms are identified as significant drivers of AMR in the environment. NEMA is responsible for licensing waste transporters and approving disposal sites, playing a direct role in preventing the release of antimicrobial residues and resistant bacteria into soil and water systems.

Secondly, NEMA's functions in **pollution control** are directly relevant. The authority is tasked with setting and enforcing standards for effluents, air quality, and general environmental pollution. Contaminated water sources, often a result of inadequate wastewater treatment from healthcare facilities and pharmaceutical manufacturing, serve as reservoirs for resistant microorganisms. By enforcing stringent effluent discharge standards and monitoring compliance, NEMA can significantly reduce the environmental load of antimicrobials and resistant genes.

Thirdly, the requirement for **Environmental Impact Assessments (EIAs) and Environmental Audits** under EMCA offers a proactive mechanism for AMR mitigation. Projects with the potential to generate significant antimicrobial waste or release residues, such as pharmaceutical manufacturing plants, large-scale livestock farms, and healthcare facilities, should undergo thorough EIAs that specifically assess AMR risks. Environmental audits then serve as follow-up tools to ensure ongoing compliance with environmental management plans designed to mitigate these risks.

Despite this clear legal foundation, the effective integration of environmental considerations into Kenya's AMR response faces significant challenges. A key issue is the historical underrepresentation and underfunding of environmental agencies within the "One Health" framework, with human and animal health sectors often dominating policy and implementation. This has led to environmental dimensions of AMR being largely overlooked, resulting in critical pathways like contaminated wastewater and agricultural run-off receiving less attention. While the National Action Plan on AMR (2023-2027) has made strides in more comprehensively incorporating the environment sector compared to its predecessor (2017-2022), structural obstacles such as limited inter-agency communication, fragmented responsibilities, and weak enforcement persist.

Furthermore, specific guidelines, such as the Pharmacy and Poisons Board's Guidelines for Safe Management of Pharmaceutical Waste, developed in collaboration with NEMA, provide a detailed framework for handling pharmaceutical waste. The Pharmacy and Poisons (Pharmaceutical Waste Management) Rules, 2022 (Legal Notice No. 99 of 2022), further stipulate obligations for waste generators. However, enforcement remains a concern, particularly regarding improper disposal practices by smaller facilities and individuals, and the availability of antibiotics without prescription, which fuels misuse and subsequent environmental contamination. The lack of dedicated budgets and specific environmental-AMR indicators further hampers NEMA's ability to fully operationalize its mandate in this critical area.

NEMA's role in combating Antimicrobial Resistance in Kenya is indispensable, forming a crucial pillar of the nation's "One Health" strategy. Its statutory mandate under the Environmental Management and Co-ordination Act, 1999, provides the legal instruments necessary to address the environmental pathways of AMR, particularly through robust waste management, pollution control, and environmental impact assessment frameworks. The proper disposal of pharmaceutical waste, management of hospital and industrial effluents, and control of agricultural run-off are all areas where NEMA's oversight is critical to preventing the spread of resistant microorganisms.

For legal practitioners, understanding NEMA's expanded role in AMR is vital. Advising clients, particularly those in the healthcare, pharmaceutical, and agricultural sectors, must now extend beyond traditional environmental compliance to encompass specific AMR mitigation measures in waste and effluent management. This includes ensuring strict adherence to the Pharmacy and Poisons (Pharmaceutical Waste Management) Rules, 2022, and related guidelines, as well as integrating AMR considerations into environmental due diligence and impact assessments. Moving forward, there is a clear imperative to strengthen NEMA's capacity, provide dedicated funding, and foster genuine multi-sectoral collaboration to elevate the environmental dimension of AMR to its rightful prominence within Kenya's national health security agenda. Enhanced legislative backing and integrated monitoring frameworks for environmental AMR indicators will be crucial in safeguarding public health and the environment from this escalating threat.